Colinz Laboratories (BOM:531210) EBIT per Share : ₹2.05 (TTM As of Mar. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Colinz Laboratories EBIT per Share?

Colinz Laboratories's EBIT per Share for the three months ended in Mar. 2024 was ₹0.79. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹2.05.

During the past 12 months, the average EBIT per Share Growth Rate of Colinz Laboratories was -14.30% per year. During the past 3 years, the average EBIT per Share Growth Rate was 75.00% per year. During the past 5 years, the average EBIT per Share Growth Rate was 57.30% per year. During the past 10 years, the average EBIT per Share Growth Rate was 14.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Colinz Laboratories's EBIT per Share or its related term are showing as below:

BOM:531210' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -16.2 Med: -4.4 Max: 100.8
Current: 75

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Colinz Laboratories was 100.80% per year. The lowest was -16.20% per year. And the median was -4.40% per year.

BOM:531210's 3-Year EBIT Growth Rate is ranked better than
96.41% of 863 companies
in the Drug Manufacturers industry
Industry Median: 7.3 vs BOM:531210: 75.00

Colinz Laboratories's EBIT for the three months ended in Mar. 2024 was ₹1.99 Mil.

Colinz Laboratories EBIT per Share Historical Data

The historical data trend for Colinz Laboratories's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Colinz Laboratories EBIT per Share Chart

Colinz Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EBIT per Share

Get a 7-Day Free Trial

0.53

0.72

1.21

2.60

2.73

Colinz Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial															0.59	0.68	0.64	0.62	0.79

Colinz Laboratories EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Colinz Laboratories's EBIT per Share for the fiscal year that ended in Mar. 2024 is calculated as

	EBIT per Share		(A: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	6.875	/	2.522
=	2.73

Colinz Laboratories's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	1.993	/	2.518
=	0.79

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2.05

Colinz Laboratories (BOM:531210) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Colinz Laboratories EBIT per Share Related Terms

Thank you for viewing the detailed overview of Colinz Laboratories's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Colinz Laboratories (BOM:531210) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Colinz Laboratories Ltd (BOM:531210) » Definitions » EBIT per Share

Traded in Other Exchanges

N/A

Address

Mulund Goregaon Link Road, A-101 Pratik Industrial Estate, Next to Fortis Hospital, Bhandup (West), Mumbai, MH, IND, 400078

Website

http://www.colinz.com

Colinz Laboratories Ltd is an India based company engaged in manufacturing of pharmaceutical formulations. It offers formulations in the products category of ayurvedic, allopathy, and nutraceuticals. The company manufactures pharmaceutical formulations in the dosage forms of tablets, capsules, granules, liquid orals, injectables, ointments, creams, and others. It also has certain specialized products for gynecology, cardiology, gastroenterology, and others. The group derives revenue from the sale of its products in India.

Colinz Laboratories (BOM:531210) Headlines

No Headlines